The disclosure generally relates to a cell culture well article and methods of making and using the article
In embodiments, the disclosure provides a well article for culturing and assaying, for example, spheroidal cell masses. The well article includes at least one chamber having an opaque side wall; a transparent, round or concave bottom surface; and the transparent bottom is gas-permeable.
In embodiments, the disclosure provides methods for making the well article, and methods of using the well article in spheroid cell culture or in cellular assays.
In embodiments, the disclosure also provides a multi-well plate article having wells or chambers with opaque walls and a gas-permeable, transparent round-bottom, and methods for making the round-bottom multi-well plate article. The transparent round-bottom, such as an optically clear bottom window, permits convenient microscopic visualization or examination of the cultured spheroid cell mass.
In embodiments, the disclosure provides a well plate having a base, the base having a conical or tapered geometry, such as a forty five degree (45°) angle, or like taper angles, from the sidewall to a radius at the apex (i.e., the very bottom of the well) to provide a round-bottom well or multiwell plate having an opaque sidewall and an optically clear window or base for optical visualization, such as with a microscopic or like devices, of a spheroid cell culture.
In embodiments of the disclosure:
Various embodiments of the disclosure will be described in detail with reference to drawings, if any. Reference to various embodiments does not limit the scope of the invention, which is limited only by the scope of the claims attached hereto. Additionally, any examples set forth in this specification are not limiting and merely set forth some of the many possible embodiments of the claimed invention.
In embodiments, the disclosed apparatus and the disclosed method of making and using the apparatus provide one or more advantageous features or aspects, including for example as discussed below. Features or aspects recited in any of the claims are generally applicable to all facets of the invention. Any recited single or multiple feature or aspect in any one claim can be combined or permuted with any other recited feature or aspect in any other claim or claims.
“Include,” “includes,” or like terms means encompassing but not limited to, that is, inclusive and not exclusive.
“About” modifying, for example, the quantity of an ingredient in a composition, concentrations, volumes, process temperature, process time, yields, flow rates, pressures, viscosities, and like values, and ranges thereof, or a dimension of a component, and like values, and ranges thereof, employed in describing the embodiments of the disclosure, refers to variation in the numerical quantity that can occur, for example: through typical measuring and handling procedures used for preparing materials, compositions, composites, concentrates, component parts, articles of manufacture, or use formulations; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of starting materials or ingredients used to carry out the methods; and like considerations. The term “about” also encompasses amounts that differ due to aging of a composition or formulation with a particular initial concentration or mixture, and amounts that differ due to mixing or processing a composition or formulation with a particular initial concentration or mixture.
“Optional” or “optionally” means that the subsequently described event, circumstance, or structure, can or cannot occur, and that the description includes instances where the event, circumstance, or structure, occurs and instances where it does not.
“Consisting essentially of” or “consisting of” in embodiments can refer to, for example:
The article, the method of making the article, and the method of using the article, of the disclosure can include the components or steps listed in the claim, plus other components or steps that do not materially affect the basic and novel properties of the compositions, articles, apparatus, or methods of making and use of the disclosure, such as a particular article configuration, particular additives or ingredients, a particular agent, a particular structural material or component, a particular irradiation or temperature condition, or like structure, material, or process variable selected.
The indefinite article “a” or “an” and its corresponding definite article “the” as used herein means at least one, or one or more, unless specified otherwise.
Abbreviations, which are well known to one of ordinary skill in the art, may be used (e.g., “h” or “hrs” for hour or hours, “g” or “gm” for gram(s), “mL” for milliliters, and “rt” for room temperature, “nm” for nanometers, and like abbreviations).
Specific and preferred values disclosed for components, ingredients, additives, dimensions, conditions, and like aspects, and ranges thereof, are for illustration only; they do not exclude other defined values or other values within defined ranges. The apparatus and methods of the disclosure can include any value or any combination of the values, specific values, more specific values, and preferred values described herein, including explicit or implicit intermediate values and ranges.
The formation of uniformly-sized spheroids of, for example, tumor cells, can be facilitated if the cells are cultured in a round-bottom vessel that has low-adhesion properties. Researchers from the Institute of Cancer Research in Sutton, UK, used Corning, Inc.'s, ultra-low-adhesion (ULA)-coated 96-well clear, round-bottom, polystyrene microplates to produce tumor spheroids that enabled target validation and drug evaluation (see Vinci et al., BMC Biology, 2012, 10:29). The spheroids enhanced the biological relevance of the tumor cell cultures and facilitated a range of functional assays. The round-bottom well shape along with gravity and the ultra-low attachment coat or coating, encouraged the cells to come together and self-assemble into the spheroid shape rather than to form a monolayer of cells.
While the clear, round-bottom, ULA-coated wells of the 96-well plate were utilized with good results for migration and invasion assays due to the optical clarity of the structural polymer, evaluation of anti-cancer agents using fluorescent or luminescent detection in this plate were less optimal since the clear sidewalls added to the noise in the detected signal. While the tumor cells could be moved into opaque 96-well plates, this calls for pipetting the spheroids, which can be delicate, difficult, and time-consuming.
In embodiments, the present disclosure provides a spheroid cell culture article comprising:
The disclosed well plate having a well base having a conical or tapered geometry is superior for injection molding of the well's opaque side wall since it is unnecessary to alter existing flat pins that have been previously used to over-mold on a flat insert (i.e., base). Injection molding with existing flat pins can also be accomplished on a well-bottom geometry having a full radius (i.e., a hemispherical or untapered base). An optional distortion collar feature on the base can enhance the ability of an existing flat pin to achieve shut-off on the well-bottom geometry.
A well plate having the disclosed tapered or chevron shaped (e.g., a 45 degree angle from the sidewall to a radiused apex) well-bottom geometry has been successfully demonstrated for use in the formation of cell spheroids. The tapered well-base or well-bottom geometry also enables over-molding of the opaque well wall onto an insert (base) pre-formed with the tapered geometry using existing flat pins that would ordinarily be used to over-mold on a flat insert. The optional distortion collar feature integral with or attached to the insert (base) can facilitate resin flow shut-off of the injection molding pin. The well-bottom geometry can alternatively be generated by thermal-forming a polymer film prior to over-molding, or after over-molding using a thermal reforming process. Thermal reforming permits rapid change-over to generate well geometries for alternative multiple formats.
The disclosed well plate having a tapered or chevron shaped base (e.g., an approximate 45 degree angle) is advantaged by, for example, permitting over-molding onto the insert using the same pin equipment to over-mold on a flat insert. This over-molding can be facilitated by the addition of a distortion collar that can flex to permit the pin to shut-off the polymer flow. Using the flat pin for molding results in saving time and reducing cost for the generation of this well plate product since the mold-cavity pins do not need to be modified for different well geometries or different well count formats.
Thermal reforming permits rapid change-over to generate well geometries for many different well formats. Thermal reforming also permits design flexibility for assessment of different well geometries for each format and the ability to rapidly produce prototype or production samples for customer evaluation or specification.
A well base having an approximate 45 degree tapered angle also allows for a smaller radiused apex, which apex centers the collection of cells that settle by gravity to form a cell spheroid, and enhances optical imaging.
Referring to the Figures,
Well plates having opaque sidewalls and gas permeable, rounded-bottom wells having clear windows can provide significant advantages including, for example: no need to transfer the spheroid from one multiwell plate (in which spheroids can be formed and visualized) to another plate for conducting assays to, for example, evaluate drug compounds; avoiding the spheroid transfer step can save time and avoid potential loss or disruption of the spheroid; and the spheroids can receive superior oxygenation with well-bottoms made from a polymer having gas permeable properties at a given wall thickness. Increased oxygen availability to the cells in the spheroid culture is particularly helpful for cells with high oxygen requirements such as hepatocytes.
In embodiments, the article having a chamber having at least one concave arcuate surface can include, for example, a plurality of adjacent concave arcuate surfaces having, for example, from 1 to about 1,000 concave arcuate surfaces on the bottom of the same chamber, see for example,
In embodiments, the article can be, for example, a single well or multi-well plate configuration having numerous “spheroidal wells”, such as a plurality of dimples or pits in the bottom or base of each well. The plurality of spheroids or spheroid wells per chamber can preferably accommodate, for example, a single or one spheroid per spheroid well.
In embodiments, the gas permeable, transparent well bottom having the at least one concave arcuate surface or “cup” can be, for example, a hemi-spherical surface, a conical surface having a rounded bottom, and like surface geometries, or a combination thereof. The well and well bottom ultimately terminates, ends, or bottoms-out in a spheroid “friendly” rounded or curved surface, such as a dimple, a pit, and like concave frusto-conicial relief surfaces, or combinations thereof.
In embodiments, the opaque side wall surface (i.e., a surround) can be, for example, a vertical cylinder or shaft, a portion of a vertical conic of decreasing diameter from the chamber top to the chamber bottom, a vertical square shaft or vertical oval shaft having a conical transition, i.e., a square or oval at the top of the well, transitioning to a conic, and ending with a bottom having at least one concave arcuate surface, i.e., rounded or curved, or a combination thereof. Other illustrative geometric examples include holey cylinders, holey conic cylinders, first cylinders then conics, and other like geometries, or combinations thereof.
In embodiments, the article can further comprise, for example, a low-adhesion or no-adhesion coating on a portion of the chamber, such as on the at least one concave arcuate surface.
In embodiments, the article can further comprise, for example, a chamber annex, chamber extension area, or an auxiliary side chamber, for receiving a pipette tip for aspiration, the chamber annex or chamber extension (e.g., a side pocket) can be, for example, an integral surface adjacent to and in fluid communication with the chamber. The chamber annex can have a second bottom spaced away from the gas-permeable, transparent bottom. The chamber annex and the second bottom of the chamber annex can be, for example spaced away from the gas-permeable, transparent bottom such as at a higher elevation or relative altitude. The second bottom of the chamber annex deflects fluid dispensed from a pipette away from the transparent bottom to avoid disrupting or disturbing the spheroid.
In embodiments, the article can further comprise a porous membrane, such as a liner or membrane insert, situated within a portion of the chamber, situated within a portion of the chamber annex, or both the chamber and the chamber annex portion. The porous membrane can provide isolation or separation of a second cellular material, such as a different cell type or different cell state, situated in an upper portion of the chamber, in an upper portion of the chamber formed by the porous membrane, or both chambers, from first cellular material in a lower portion of one or both chambers near the transparent bottom.
In embodiments, the at least one concave arcuate surface can be, for example, a hemisphere, or a portion of a hemisphere, such as a horizontal section or slice of a hemisphere, having a diameter of, for example, from about 250 to about 5,000 microns (i.e., 0.010 to 0.200 inch), including intermediate values and ranges, depending on, for example, the well geometry selected, the number of concave arcuate surfaces within each well, the number of wells in a plate, and like considerations. Other concave arcuate surface can have, for example, parabolic, hyperbolic, chevron, and like cross-section geometries, or combinations thereof.
In embodiments, the spheroid can be, for example, substantially a sphere, having a diameter of, for example, from about 100 to about 500 microns, more preferably from about 150 to about 400 microns, even more preferably from about 150 to about 300 microns, and most preferably from about 200 to about 250 microns, including intermediate values and ranges, depending on, for example, the types of cells in the spheroid. Spheroid diameters can be, for example, from about 200 to about 400 microns, and the upper diameters being constrained by diffusion considerations (for a review of spheroids and spheroid vessels see Achilli, T-M, et. al. Expert Opin. Biol. Ther. (2012) 12(10)).
In embodiments, the disclosure provides a perfusion plate apparatus comprising:
In embodiments, the aforementioned perfusion plate apparatus can further comprise, for example: a source liquid (not shown), a perfusion plug (655), i.e., liquid permeable material, situated in a liquid connection member (635), such as a tube, between a source well (630) and the cell culture rounded-bottom well of the apparatus (600), a perfusion plug (655) situated in a liquid connection member (645) between the cell culture rounded-bottom well and the waste well (640), or both situations. The waste well (640) preferably can have an arcuate bottom surface to facilitate removal of waste liquid medium (not shown) using, for example, a pipette, a vacuum pump, or like liquid removal equipment.
A related but distinct cell culture article (i.e., FloWell™ plate) is disclosed in commonly owned and assigned copending application, U.S. Provisional Patent Application Ser. No. 61/594,039, filed on Feb. 2, 2012, now PCT/US13/24030, to Goral, et al., entitled “Automatic continuous perfusion cell culture microplate consumables”. The related application mentions, for example, a microplate for culturing cells with automatic, continuous perfusion of a liquid medium, and can include, for example, a well frame which defines a plurality of cavities therethrough. The microplate can further include a planar substrate connected with the well frame. The planar substrate can provide a bottom surface to the plurality of cavities, forming a plurality of wells. The plurality of wells may include a first well, a second well fluidly connected with the first well, and a third well fluidly connected with the first well. The first well may be employed for culturing the cells in the liquid medium. The second well may be employed for providing an outflow or source of the liquid medium to the first well. The third well may be employed for receiving an inflow or waste stream of the liquid medium from the first well. The second well may be fluidly connected with the first well with a first perfusion membrane. A first perfusion membrane can be disposed in between the well frame and the planar substrate and may extend from an outlet section of the second well to an inlet section of the first well. The third well may be fluidly connected with the first well with a second perfusion membrane. The first and second perfusion membranes can have a porosity of, for example, from about 0.2 to about 200 microns. The second perfusion membrane can be disposed in between the well frame and the planar substrate and extend from an outlet section of the first well to an inlet section of the third well. Upon introduction of a perfusion-initiating amount of the liquid medium into the second well, the liquid medium flows from the second well through the first perfusion membrane to the first well and from the first well through the second perfusion membrane to the third well (see for example
In embodiments, the article having a chamber can include, for example, from 1 to about 2,000 chambers, from 10 to about 1,500 chambers, including intermediate values and ranges, and each chamber is physically separated from any other chamber, and each chamber has a single concave arcuate surface. In embodiments, such a multi-well plate product configuration can have, for example, one spheroid per chamber.
In embodiments, the at least one concave arcuate surface can have, for example, a plurality of adjacent concave arcuate bottom surfaces within the same well. In embodiments, a single well or multi-well plate configuration can have numerous spheroidal wells, such as dimples or pits in the bottom or base of each well. In embodiments, the article can accommodate a plurality of isolated spheroids in separated spheroid wells in a single chamber, preferably having, for example, one spheroid per spheroid well.
In embodiments, the disclosure provides a method of making an article, the article comprising:
The method of making the article can further comprise, for example, inserting a porous membrane in at least one of the chambers.
There are several methods that can be used to make an opaque round-bottom multiwell plate having opaque sidewalls and a base with a clear window. The multiwell plate made by Examples 1 or 2, and having flat well bottom geometry can be subsequently thermally-reformed to create an alternative well-bottom geometry. A multiwell plate having a flat well-bottom geometry can be, for example, positioned in a nest that has at each well-bottom position areas removed from the nest that have a circular perimeter in roughly the same dimensions as the well format, or the nest can have a tapered angle, for example, from about 30 to about 60 degrees, including intermediate values and ranges, such as 40 to 50, and 45 degrees, turning into a radius at the apex, that is, rounded at the very bottom of the well. A heated platen, heated for example at 180 to 400 degrees F., more preferably 250 to 300 degrees F., having an array of pins that have, for example, a matching 45 degree tapered angle from the sidewall sloping into a radius at the apex, is held stationary, with a pin positioned over each well. The pin-platen is actuated so that the pins descend into the wells of the multiwell plate to contact the clear flat well-bottom surface. Time, temperature, and pressure can change the well-bottom material geometry as the pins advance until the reformed well-bottom material meets the matching nest geometry. The array of pins may be coated with a release agent, such as PTFE, to prevent the reformed well-bottom geometry from sticking to the heated pins, or the pins can be uncoated. The nest may also have a vacuum assist on the nest to help draw the polymer into the well geometry. Cooling air can be injected into the top of the wells above the heated pins to cool the hot pins slightly and facilitate their release from the polymer of the reformed well-bottom geometry. The platen with the pin array and the nest with the matching geometry can be rapidly changed to comply with many multiple well formats, including 384- and 1536-wells. Any number of wells may be reformed at the same time. In embodiments, the pin-platen can be held stationary while the nest holding the insert can be actuated to be brought into contact with the stationary pin-platen. In embodiments, both the pin-platen and the nest holding the insert can be actuated to provide relative motion that achieves contact and closure between the pins and the wells of the insert.
A v-shaped well base geometry having, for example, a tapered angle of 45 degrees, sloping from the well sidewall to a radius at the apex, is superior for spheroid formation and superior for optical measurement compared to a hemispherical well-bottom geometry. The v-shaped well base geometry also permits overmolding on the well base geometry using the same flat pins that can be used to over-mold opaque polymer onto a flat insert. The 45 degree well base tapered angle permits the pins to contact each well base on the bottom tapered sidewall. While this can also be done with a hemispherical geometry, it is more difficult. If the pin is not able to shut-off on the sidewall, the opaque polymer can leak into or onto the clear well bottom. Alternatively, if the pin cannot achieve shut-off on the sidewall, the pin can be made larger than the well, and achieve shut-off on the flat area surrounding each well at the top of the insert. This alternative solution is not desired because it can create a flat ledge within each well upon which cells can settle. Cells that settle on the ledge cannot contribute to the spheroid in the center of the well bottom, but can cause large variation in experimental results.
In embodiments, the post-forming equipment can have, for example, a heated pin, such as a single pin, a row of pins, or an array of pins, that can match the number and alignment of, for example, a single well or a plurality of wells in a row or an array of wells of an injection molded microwell plate. The geometry at the end of each pin can have, for example, a 45 degree angle or taper from the sidewall and have a radius at or near the apex.
In embodiments, an injection molded plate having a flat well-bottom geometry can be situated and secured in a nest for the post-forming step where the heated pin or pin array assembly is pressed, for example, into the flat well-bottoms of an injection molded microplate. The nest can have a matching 45 degree angle at each well position to match and receive the pin shape. In embodiments, a platen can hold the heated pin or pins and the nest holds the matching well-bottom geometry. The plane of the pin platen and the plane of the nest can be aligned in parallel and both can be perpendicular to a common axis for proper reversible and reproducible pressing.
The platen, the nest, or both, can be rapidly interchanged to accommodate other multiwell plate formats such as 384- and 1536-well plates. The platen bearing the heated pin(s) can be pressed into a matching well(s) of the multiwell plate to form the selected geometry defined by the geometry or cross-section of the pin's tip, such as hemispherical, conical, v-shaped, w-shaped, wedged shaped, and like geometries, or combined geometries, in the clear base of the well.
In embodiments, the disclosure provides a method of culturing spheroids comprising, for example:
There are several methods that can be used to make the disclosed article or articles. In embodiments, the disclosed article can be, for example, a multiwell plate having an opaque side wall for the wells and having an arcuate or concave rounded base or bottom surface, the base or bottom surface can be gas permeable and transparent or clear to visible light.
Commonly owned and assigned U.S. Pat. No. 7,674,346, mentions methods of making well plates such as bonding a polymeric holey plate to a glass or polymeric base and using, for example, heat or radiation to weld a gas permeable thin film to a holey plate to form the bottom of microplates (see e.g., col 2, lines 4 to 44).
Commonly owned and assigned U.S. Pat. No. 5,759,494, mentions methods of making well plates having opaque sidewalls by, for example, over-molding inserts to prevent cross-talk. Polymethylpentene (TPX) of the presently disclosed gas permeable spheroid plate can be selected as a suitable base or wall material that can be used in methods of making in the '494 patent and the present disclosure.
In embodiments, the structure of the presently disclosed gas permeable spheroid plate can also include one or more ridges arranged in one or more grid patterns as disclosed in the '494 patent, see for example, col. 4, line 30 to col. 5, line 54, to further reduce or prevent cross-talk. In over-molded plates without a grid, the perimeter of the well, a film, tended to peel away from the molded plate body. The grid appears to keep the film from peeling away from the plate body as it is reforming. The grid also appears to prevent stress marks from appearing in the film, since stress marks do appear in the plates without the grid.
U.S. Pat. No. 6,811,752, mentions methods of making a device having micro-chambers and microfluidic flow, and gas permeable, liquid impermeable membranes.
In one method (insert molding), the multiwell plate bottom or base portion having at least one rounded, cupped, or dimpled impression in the base is injection molded, or thermoformed using a clear polymer. Next, the molded or thermoformed clear multiwell bottom plate is inserted into a vertical press, then an opaque polymer is injected forming the remainder of the multiwell plate onto the clear, round well bottoms. An alternative to insert molding uses a 2-shot molding process.
Referring again to the Figures,
The following examples serve to more fully describe the manner of using the above-described disclosure, and to further set forth best modes contemplated for carrying out various aspects of the disclosure. These examples do not limit the scope of this disclosure, but rather are presented for illustrative purposes. The working example(s) further describe(s) how to prepare the disclosed cell culture well articles.
Injection Mold or Thermoform Methods
In another method of making, one can mold or thermoform an opaque multiwell plate that has no well-bottoms (i.e., make an opaque “holey plate”). Next, one can injection mold, or thermoform the multiwell plate bottom or base portion using a clear polymer. Then one can attach the holey plate and base components together using any of various assembly processes, including, for example, adhesive, ultrasonic, IR, thermal, laser welding, and like processes.
In another method of making, one can injection mold, or thermoform the entire well of a multiwell plate (without a skirt) using a clear polymer. Next, one can injection mold, or thermoform another multiwell plate (including the skirt) but without well bottoms using an opaque polymer. The well diameters of the opaque plate are molded to be slightly larger than the well diameters of the clear plate. The opaque plate acts as a sleeve to receive the clear plate and thus form opaque sidewalls and with a clear window at the base of the well.
In another method of making, one can distortion print an opaque coating on the exterior of a clear polymer sheet, leaving a clear zone in the area that will be thermoformed with, for example, a cup or dimple, or multiples thereof, into the center of the well bottom. Once thermoformed into a multiwell plate, all of the plate will appear opaque except for the clear zone that forms a window for optical viewing.
Non-Adhesive Coating
The interior well-bottom surface, walls, or both can optionally be made non-adhesive to cells by coating those surfaces with a polymer that does not have any characteristics that promote cell attachment, such as a perfluorinated polymer, olefin, or like polymers, and mixtures thereof. Alternatively, following assembly of the opaque multiwell plate with clear, round or cupped well-bottoms, the interior well-bottom may be coated with a non-binding material such as an ultra-low attachment material, agarose, nonionic hydrogel, or like materials, that can inhibit cell attachment. Coatings can also be applied to the clear well bottom portion of the multiwell plate prior to joining with the opaque portion. The combination of, for example, a low-attachment substrate, the well curvature in the body and the base portions, and gravity, can induce cells to self-assemble into spheroids, which cell clusters are known to maintain differentiated cell function indicative of a more in-vivo like response (see Messner, et al., Archives of Toxicology, Nov. 11, 2012). Perfluorinated polymers or polymers such as poly 4-methylpentene also provide gas permeability at thicknesses normally used in molding processes, which gas permeability can be beneficial for metabolically active cell types. Representative thickness and ranges of gas permeable polymer can be, for example, from about 0.001 inch to about 0.025 inch, from 0.0015 inch to about 0.03 inch, including intermediate values and ranges (where 1 inch=25,400 microns; 0.000039 inches=1 micron). Additionally or alternatively, other materials having high gas permeabilities, such as polydimethylsiloxane polymers, can provide sufficient gas diffusion at a thickness, for example, of up to about 1 inch.
Post Forming Method Another method of making a well plate article of the disclosure is accomplished by thermal reforming. In the thermal reforming method a commercially available plate, for example, having standard black (opaque) side-walls and a clear flat plastic bottom is selected. Using a combination of vacuum on the outside and pressure supplied by a hot forming tool with a full radius pushed into the interior of the well(s) on the opposite side of the plate and further into the bottom of the well, the concave arcuate base or tapered base having a round bottom radius is formed in the well bottom. The outside bottom area can be, for example, preheated with IR radiation to facilitate forming the cupped or internal concave arcuate bottom radius, or the tapered base.
Method of Use; Culturing of Cells
Image 11A shows a spheroid in an all clear control 96-well plate (i.e., the walls of this comparative plate are transparent) having a full hemisphere well-bottom geometry.
Image 11B shows a spheroid in a prototype thermally reformed 96-well plate having a v-shaped or 45 degree tapered well-bottom geometry.
Image 11C shows a spheroid in an injection-molded single well with the v-shaped or 45 degree well-bottom geometry.
Image 11D shows a spheroid in an injection-molded single well having a full hemisphere well-bottom geometry.
HT-29 cells were seeded into wells including the comparative well (11A) and inventive v-shaped wells (11B and 11C) and hemisphere shaped well (11D) at a concentration of 10,000 cells per well, and incubated for 96 hours at 37 degrees C. in an incubator with 5% CO2 and 85% humidity. The
The cell seeding procedure generally included the following steps: trypsinize; count the cells; centrifuge to remove medium from the cells; and re-suspend the cells. Seeding densities can be, for example: 10 k, 20 k or 30 k cells per well. The seeding volume can be, for example, 200 microliters per well. Monitoring images can be recorded, for example, at 30 minutes, at 24 hrs, and at 96 hrs after seeding, including intermediate values and ranges.
The spheroids in images 11B and 11C are in the center of the v-shaped well base. The spheroids in images 11A and 11D are not in the center of the hemisphere. The v-shaped base geometry appears to promote centering of the spheroids in the center of the well base, which centering facilitates optical visualization.
In embodiments, one can form a gas permeable, rounded well-bottom using the thermal reforming process. In existing methods, the plates can be molded on flat inserts of, for example, polystyrene that is 0.005″, which thickness is considered not gas permeable. However, during the thermal reforming process, one can decrease the thickness of the insert at the radiused apex to, for example, about 0.003″ (photograph not included), which makes the well-bottom as gas permeable as the HYPER-product film (which is also 0.003″ thick polystyrene).
The disclosure has been described with reference to various specific embodiments and techniques. However, it should be understood that many variations and modifications are possible while remaining within the scope of the disclosure.
This application is filed under 35 U.S.C. § 111 as a continuation application of U.S. patent application Ser. No. 15/708,473, filed Sep. 19, 2017, which is a continuation application of U.S. application Ser. No. 14/087,906, filed on Nov. 22, 2013, which claims the benefit of priority to U.S. Provisional Application No. 61/817,539 filed on Apr. 30, 2013, the content of which is relied upon and incorporated herein by reference in its entirety. The entire disclosure of any publication or patent document mentioned herein is incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2947116 | Wilton et al. | Aug 1960 | A |
3630849 | David et al. | Dec 1971 | A |
4382685 | Pearson | May 1983 | A |
4498785 | De Bruyne | Feb 1985 | A |
4534656 | De Bruyne | Aug 1985 | A |
4670396 | Bear et al. | Jun 1987 | A |
4760028 | De Bruyne et al. | Jul 1988 | A |
4927764 | Lyman et al. | May 1990 | A |
4980293 | Jeffs | Dec 1990 | A |
5047347 | Cline | Sep 1991 | A |
5151366 | Serkes et al. | Sep 1992 | A |
5171994 | Bahraman | Dec 1992 | A |
5171995 | Gast et al. | Dec 1992 | A |
5240854 | Berry et al. | Aug 1993 | A |
5272084 | O'Connell et al. | Dec 1993 | A |
5319436 | Manns | Jun 1994 | A |
5374557 | Verma | Dec 1994 | A |
5398837 | Degrassi | Mar 1995 | A |
5487872 | Hafeman et al. | Jan 1996 | A |
5554536 | Rising | Sep 1996 | A |
5598262 | Jutard et al. | Jan 1997 | A |
5665562 | Cook | Sep 1997 | A |
5693537 | Wilson et al. | Dec 1997 | A |
5707869 | Wolf et al. | Jan 1998 | A |
5710043 | Pay | Jan 1998 | A |
5736397 | Garcia et al. | Apr 1998 | A |
5759494 | Szlosek | Jun 1998 | A |
5766949 | Liau et al. | Jun 1998 | A |
5772905 | Chou | Jun 1998 | A |
5783440 | Stevens | Jul 1998 | A |
5792653 | Weibezahn et al. | Aug 1998 | A |
5858309 | Mathus et al. | Jan 1999 | A |
5972694 | Mathus | Oct 1999 | A |
6030829 | Dannoux et al. | Feb 2000 | A |
6039972 | Barlow et al. | Mar 2000 | A |
6306646 | Saad et al. | Oct 2001 | B1 |
6348999 | Summersgill et al. | Feb 2002 | B1 |
6514464 | Knebel | Feb 2003 | B1 |
6521451 | Potter | Feb 2003 | B2 |
6567675 | Rosen et al. | May 2003 | B1 |
6767607 | Tanner et al. | Jul 2004 | B2 |
6811752 | Barbera-Guillem | Nov 2004 | B2 |
6908767 | Bader | Jun 2005 | B2 |
7470424 | Kataoka et al. | Dec 2008 | B2 |
7547547 | Dang et al. | Jun 2009 | B2 |
7674346 | Clements et al. | Mar 2010 | B2 |
7687262 | Cattadoris | Mar 2010 | B2 |
7691369 | Kataoka et al. | Apr 2010 | B2 |
7727759 | Ozawa et al. | Jun 2010 | B2 |
7745209 | Martin et al. | Jun 2010 | B2 |
7745210 | Martin | Jun 2010 | B2 |
7897379 | Kenney et al. | Mar 2011 | B2 |
7919319 | Jervis et al. | Apr 2011 | B2 |
8053230 | Whittlinger | Nov 2011 | B2 |
8143053 | Yerbic | Mar 2012 | B2 |
8148152 | Kolossov et al. | Apr 2012 | B2 |
8158426 | Wilson et al. | Apr 2012 | B2 |
8158427 | Wilson et al. | Apr 2012 | B2 |
8163537 | Martin et al. | Apr 2012 | B2 |
8168432 | Wilson et al. | May 2012 | B2 |
8178345 | Bennett et al. | May 2012 | B2 |
8273572 | Martin et al. | Sep 2012 | B2 |
8318479 | Domansky et al. | Nov 2012 | B2 |
8415144 | Wilson et al. | Apr 2013 | B2 |
8470589 | Martin et al. | Jun 2013 | B2 |
D685497 | Kenney et al. | Jul 2013 | S |
8486692 | Simon | Jul 2013 | B2 |
8597597 | Deutsch et al. | Dec 2013 | B2 |
8617879 | Yu et al. | Dec 2013 | B2 |
8697443 | Wilson et al. | Apr 2014 | B2 |
8759017 | Owen et al. | Jun 2014 | B2 |
8778669 | Lacey et al. | Jul 2014 | B2 |
8846399 | Martin et al. | Sep 2014 | B2 |
8906685 | Takayama et al. | Dec 2014 | B2 |
8932544 | Mueller et al. | Jan 2015 | B2 |
9039883 | Guerrieri et al. | May 2015 | B2 |
9040293 | Gulzow et al. | May 2015 | B2 |
9045721 | Martin et al. | Jun 2015 | B2 |
9068281 | Wu et al. | Jun 2015 | B2 |
9126199 | Moritz et al. | Sep 2015 | B2 |
9169460 | Cecchi | Oct 2015 | B2 |
D748812 | Kenney et al. | Feb 2016 | S |
9260684 | Egeler et al. | Feb 2016 | B1 |
9260695 | Crowley et al. | Feb 2016 | B2 |
9493733 | Giles | Nov 2016 | B2 |
9494577 | Mcgarr et al. | Nov 2016 | B2 |
9573128 | McClelland | Feb 2017 | B1 |
9587213 | Morgan et al. | Mar 2017 | B2 |
9732317 | Wilson | Aug 2017 | B2 |
9790465 | Bennett et al. | Oct 2017 | B2 |
9845451 | Martin et al. | Dec 2017 | B2 |
9862918 | Ito | Jan 2018 | B2 |
10254274 | Miklas et al. | Apr 2019 | B2 |
11441121 | Bennett | Sep 2022 | B2 |
20020022219 | Clements et al. | Feb 2002 | A1 |
20020172621 | Barbera-Guillem | Nov 2002 | A1 |
20030031829 | Tanner et al. | Feb 2003 | A1 |
20030104494 | Ravkin et al. | Jun 2003 | A1 |
20030183958 | Goff et al. | Oct 2003 | A1 |
20030186217 | Bader | Oct 2003 | A1 |
20030215941 | Campbell et al. | Nov 2003 | A1 |
20040091397 | Picard | May 2004 | A1 |
20040101955 | Whitley | May 2004 | A1 |
20040125266 | Miyauchi et al. | Jul 2004 | A1 |
20040216835 | Tanner et al. | Nov 2004 | A1 |
20040259242 | Malinge et al. | Dec 2004 | A1 |
20040259423 | Elbaz et al. | Dec 2004 | A1 |
20050032208 | Oh et al. | Feb 2005 | A1 |
20050047971 | Clements et al. | Mar 2005 | A1 |
20050074873 | Shanler et al. | Apr 2005 | A1 |
20050112030 | Gaus | May 2005 | A1 |
20050116717 | Dransfield et al. | Jun 2005 | A1 |
20050147959 | Frondoza et al. | Jul 2005 | A1 |
20060110822 | Robbins et al. | May 2006 | A1 |
20060234370 | Korpinen et al. | Oct 2006 | A1 |
20060252044 | Okumura et al. | Nov 2006 | A1 |
20060292654 | Reardon | Dec 2006 | A1 |
20070178441 | Li | Aug 2007 | A1 |
20070216897 | Sonda | Sep 2007 | A1 |
20080003671 | Martin | Jan 2008 | A1 |
20080009027 | Fraker et al. | Jan 2008 | A1 |
20080118974 | Martin et al. | May 2008 | A1 |
20080206857 | Kenney et al. | Aug 2008 | A1 |
20080268515 | Cullimore et al. | Oct 2008 | A1 |
20080297784 | Leblanc et al. | Dec 2008 | A1 |
20080299649 | Martin et al. | Dec 2008 | A1 |
20080300278 | Torrens et al. | Dec 2008 | A1 |
20090017540 | Nishio et al. | Jan 2009 | A1 |
20090018033 | Morgan et al. | Jan 2009 | A1 |
20090029462 | Beardsley et al. | Jan 2009 | A1 |
20090037293 | Unger et al. | Feb 2009 | A1 |
20090170190 | Nishi et al. | Jul 2009 | A1 |
20090191620 | Martin et al. | Jul 2009 | A1 |
20090288963 | Guerrieri et al. | Nov 2009 | A1 |
20090298164 | Cattadoris et al. | Dec 2009 | A1 |
20090298166 | Fang et al. | Dec 2009 | A1 |
20100055774 | Wilson | Mar 2010 | A1 |
20100068793 | Ungrin et al. | Mar 2010 | A1 |
20100093075 | Rolf | Apr 2010 | A1 |
20100112014 | Gilbert et al. | May 2010 | A1 |
20100112684 | Lee et al. | May 2010 | A1 |
20100119418 | Clements et al. | May 2010 | A1 |
20100170790 | Takahashi et al. | Jul 2010 | A1 |
20100190197 | Martin et al. | Jul 2010 | A1 |
20100197013 | Kamp et al. | Aug 2010 | A1 |
20100247386 | Deutsch et al. | Sep 2010 | A1 |
20100273258 | Lannutti et al. | Oct 2010 | A1 |
20100297600 | Cecchi | Nov 2010 | A1 |
20110086375 | Ungrin et al. | Apr 2011 | A1 |
20110097790 | Yerbic | Apr 2011 | A1 |
20110129923 | Wilson et al. | Jun 2011 | A1 |
20110229961 | Higashi et al. | Sep 2011 | A1 |
20120064627 | Khine et al. | Mar 2012 | A1 |
20120129208 | Khine et al. | May 2012 | A1 |
20120129257 | Yu et al. | May 2012 | A1 |
20120219572 | Prockop et al. | Aug 2012 | A1 |
20130052331 | Kram et al. | Feb 2013 | A1 |
20130122539 | Li et al. | May 2013 | A1 |
20130122580 | Tsukada et al. | May 2013 | A1 |
20130143254 | Thomas et al. | Jun 2013 | A1 |
20130164848 | Munaka et al. | Jun 2013 | A1 |
20130203159 | Itoh et al. | Aug 2013 | A1 |
20130344598 | Nistor | Dec 2013 | A1 |
20140004086 | Peak | Jan 2014 | A1 |
20140027784 | Wada et al. | Jan 2014 | A1 |
20140099717 | Fraker et al. | Apr 2014 | A1 |
20140106394 | Ko et al. | Apr 2014 | A1 |
20140106452 | Vukasinovic | Apr 2014 | A1 |
20140120573 | Tavana et al. | May 2014 | A1 |
20140178992 | Nakashima et al. | Jun 2014 | A1 |
20140221225 | Danen et al. | Aug 2014 | A1 |
20140226004 | Son et al. | Aug 2014 | A1 |
20140227784 | Ejiri et al. | Aug 2014 | A1 |
20140315296 | Wilson | Oct 2014 | A1 |
20140322806 | Bennett et al. | Oct 2014 | A1 |
20150004686 | Goral et al. | Jan 2015 | A1 |
20150064738 | Tsukada et al. | Mar 2015 | A1 |
20150072405 | Ito | Mar 2015 | A1 |
20150184119 | Tsukada et al. | Jul 2015 | A1 |
20150247112 | Orr et al. | Sep 2015 | A1 |
20160003796 | Kranbuehl | Jan 2016 | A1 |
20160017267 | Hansen et al. | Jan 2016 | A1 |
20160040120 | Gottwald et al. | Feb 2016 | A1 |
20160137962 | Ejiri et al. | May 2016 | A1 |
20160194588 | Guenat et al. | Jul 2016 | A1 |
20160216250 | Ritter et al. | Jul 2016 | A1 |
20170067019 | Ho | Mar 2017 | A1 |
20170073625 | Kasuto et al. | Mar 2017 | A1 |
20170226455 | Fang et al. | Aug 2017 | A1 |
20170267959 | Martin et al. | Sep 2017 | A1 |
20170283757 | Carter et al. | Oct 2017 | A1 |
20170306281 | Martin et al. | Oct 2017 | A1 |
20170342363 | Fang et al. | Nov 2017 | A1 |
20180166743 | Lee et al. | Jun 2018 | A1 |
20180201888 | Miwa et al. | Jul 2018 | A1 |
20180301754 | Badding et al. | Oct 2018 | A1 |
20190006707 | Sakamoto et al. | Jan 2019 | A1 |
20200239854 | Ayano et al. | Jul 2020 | A1 |
Number | Date | Country |
---|---|---|
2004256209 | Jan 2005 | AU |
2558946 | Jan 2005 | CA |
2679011 | Sep 2008 | CA |
2848875 | Mar 2013 | CA |
2186755 | Jan 1995 | CN |
1168921 | Dec 1997 | CN |
1234112 | Nov 1999 | CN |
1867663 | Nov 2006 | CN |
1875093 | Dec 2006 | CN |
201626959 | Nov 2010 | CN |
101978041 | Feb 2011 | CN |
102105578 | Jun 2011 | CN |
102257123 | Nov 2011 | CN |
102449135 | May 2012 | CN |
102687023 | Sep 2012 | CN |
202450098 | Sep 2012 | CN |
202849407 | Apr 2013 | CN |
103080294 | May 2013 | CN |
103119151 | May 2013 | CN |
203513696 | Apr 2014 | CN |
103814125 | May 2014 | CN |
204608026 | Sep 2015 | CN |
204702760 | Oct 2015 | CN |
204714819 | Oct 2015 | CN |
204752742 | Nov 2015 | CN |
204803327 | Nov 2015 | CN |
205170866 | Apr 2016 | CN |
205669029 | Nov 2016 | CN |
205839030 | Dec 2016 | CN |
205990396 | Mar 2017 | CN |
107208025 | Sep 2017 | CN |
107460125 | Dec 2017 | CN |
8309876 | Dec 1983 | DE |
10019862 | Nov 2001 | DE |
202006017853 | Jan 2007 | DE |
102009005526 | Jul 2010 | DE |
102014214077 | Jan 2016 | DE |
102014017728 | Jun 2016 | DE |
0307048 | Mar 1989 | EP |
0605527 | Jul 1994 | EP |
0681846 | Nov 1995 | EP |
0800571 | Oct 1997 | EP |
0834552 | Apr 1998 | EP |
0965633 | Dec 1999 | EP |
1181349 | Feb 2002 | EP |
1348533 | Oct 2003 | EP |
1445022 | Aug 2004 | EP |
1988152 | Nov 2008 | EP |
2032262 | Mar 2009 | EP |
2617807 | Jul 2013 | EP |
2653531 | Oct 2013 | EP |
2759592 | Jul 2014 | EP |
2896684 | Jul 2015 | EP |
3081627 | Oct 2016 | EP |
3296018 | Mar 2018 | EP |
3351615 | Jul 2018 | EP |
3372666 | Sep 2018 | EP |
2147100 | May 1985 | GB |
03-139350 | Jun 1991 | JP |
06-038734 | Feb 1994 | JP |
06327462 | Nov 1994 | JP |
09-173049 | Jul 1997 | JP |
09-234811 | Sep 1997 | JP |
10-210866 | Aug 1998 | JP |
10-210966 | Aug 1998 | JP |
2001-106749 | Apr 2001 | JP |
2003-135056 | May 2003 | JP |
2003-180335 | Jul 2003 | JP |
2004-129558 | Apr 2004 | JP |
2004-535829 | Dec 2004 | JP |
2005-080660 | Mar 2005 | JP |
2006-121991 | May 2006 | JP |
2006-191809 | Jul 2006 | JP |
2007-510429 | Apr 2007 | JP |
3139350 | Feb 2008 | JP |
2009-017810 | Jan 2009 | JP |
2009-050194 | Mar 2009 | JP |
2009-183288 | Aug 2009 | JP |
2009-542230 | Dec 2009 | JP |
2010-088347 | Apr 2010 | JP |
2010-104327 | May 2010 | JP |
2010-518879 | Jun 2010 | JP |
2010-158214 | Jul 2010 | JP |
2011-509686 | Mar 2011 | JP |
2011-521642 | Jul 2011 | JP |
2011-172533 | Sep 2011 | JP |
2011-528226 | Nov 2011 | JP |
2012-249547 | Dec 2012 | JP |
2013-055911 | Mar 2013 | JP |
2014-132869 | Jul 2014 | JP |
2015-012827 | Jan 2015 | JP |
2015-029431 | Feb 2015 | JP |
2015-073520 | Apr 2015 | JP |
2016-002023 | Jan 2016 | JP |
5845185 | Jan 2016 | JP |
2016-093149 | May 2016 | JP |
2016-136920 | Aug 2016 | JP |
2016-136921 | Aug 2016 | JP |
2017-532970 | Nov 2017 | JP |
2018-108032 | Jul 2018 | JP |
10-2014-0113139 | Sep 2014 | KR |
10-2014-0125662 | Oct 2014 | KR |
10-2017-0008539 | Jan 2017 | KR |
9207063 | Apr 1992 | WO |
9307258 | Apr 1993 | WO |
9621851 | Jul 1996 | WO |
9815355 | Apr 1998 | WO |
9831466 | Jul 1998 | WO |
0180997 | Nov 2001 | WO |
0192462 | Dec 2001 | WO |
2004044120 | May 2004 | WO |
2004094060 | Nov 2004 | WO |
2005047464 | May 2005 | WO |
2006043267 | Apr 2006 | WO |
2007015770 | Feb 2007 | WO |
2007097120 | Aug 2007 | WO |
2008006104 | Jan 2008 | WO |
2008008149 | Jan 2008 | WO |
2008106771 | Sep 2008 | WO |
2008118500 | Oct 2008 | WO |
2008140295 | Nov 2008 | WO |
2008149039 | Dec 2008 | WO |
2008153783 | Dec 2008 | WO |
2009094125 | Jul 2009 | WO |
2009148509 | Dec 2009 | WO |
2009148512 | Dec 2009 | WO |
2010008566 | Jan 2010 | WO |
2010042072 | Apr 2010 | WO |
2010069589 | Jun 2010 | WO |
2012036011 | Mar 2012 | WO |
2012077683 | Jun 2012 | WO |
2012170232 | Dec 2012 | WO |
2013042360 | Mar 2013 | WO |
2013108293 | Jul 2013 | WO |
2013116449 | Aug 2013 | WO |
2014042162 | Mar 2014 | WO |
2014072432 | May 2014 | WO |
2014140181 | Sep 2014 | WO |
2014156455 | Oct 2014 | WO |
2014165273 | Oct 2014 | WO |
2014171782 | Oct 2014 | WO |
2014179196 | Nov 2014 | WO |
2014196204 | Dec 2014 | WO |
2015033507 | Mar 2015 | WO |
2015061907 | May 2015 | WO |
2015087369 | Jun 2015 | WO |
2016020992 | Feb 2016 | WO |
2016064757 | Apr 2016 | WO |
2016069885 | May 2016 | WO |
2016069892 | May 2016 | WO |
2016069895 | May 2016 | WO |
2016069917 | May 2016 | WO |
2016069930 | May 2016 | WO |
2016157322 | Oct 2016 | WO |
2017025584 | Feb 2017 | WO |
2017047735 | Mar 2017 | WO |
2017077163 | May 2017 | WO |
2017142410 | Aug 2017 | WO |
2018068034 | Apr 2018 | WO |
2018200893 | Nov 2018 | WO |
2019014621 | Jan 2019 | WO |
2019014627 | Jan 2019 | WO |
2019014635 | Jan 2019 | WO |
2019014636 | Jan 2019 | WO |
2019178039 | Sep 2019 | WO |
Entry |
---|
Curcio et al. “Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system.” Biomaterials 28 (2007) 5487-5497. (Year: 2007). |
Evenou et al. “Spontaneous Formation of Highly Functional Three-Dimensional Multilayer from Human Hepatoma Hep G2 Cells Cultured on an Oxygen-Permeable Polydimethylsiloxane Membrane.” Tissue Engineering: Part C vol. 16, No. 2, 2010, pp. 311-318. (Year: 2010). |
Koike et al. “Characterization of Embryo id Bodies of Mouse Embryonic Stem Cells Formed under Various Culture Conditions and Estimation of Differentiation Status of Such Bodies.” Journal of Bioscience and Bioengineering vol. I 04, No. 4, 294-299. 2007. (Year: 2007). |
Vinci et al. “Advances in establishment and analysis of threedimensional tumor spheroid-based functional assays for target validation and drug evaluation.” BMC Biology 2012, 10:29, 1-20. (Year: 2012). |
Madoux et al; “Building Phenotypic 3D Spheroid HTS Assays To Identify Synthetic Lethal Small Molecule Inhibitors of KRAS”; the Scripps Research Institute Molecular Screening Center and Department of Cancer Biology, Scripps Florida, Jupiter, Florida, Department of Pathology, Jupiter Medical Center, Jupiter, Florida. |
Markovitz-Bishitz, “A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids” Biomaterials and Biotechnology 31 (2010) pp. 8436-8444. |
Messner et al, Multi-cell type human liver microtissues for hepatotoxicity testing. Archives of Toxicology, Nov. 11, 2012, 5 pages. |
Mimetas the Organ-On-A-Chip Company; “Organ-On-A-Chip Models for Science and Pharma”; 4 Pages; (Downloaded Mar. 9, 2020); https://mimetas.com/. |
Mironov et al; “Organ Printing: Tissue Spheroids as Buliding Blocks” Biomaterials, 2009; 30 (12) 2164-2174. |
Moon et al; “Optimizing Human Embryonic Stem Cells Differentiation Efficiency By Screening Size-Tunable Homogenous Embryoid Bodies”; Biomaterials; 35 (2014) 5987-5997. |
Murphy et al; “3D Bioprinting of Tissues and Organs”; Nature Biotechnology, vol. 32, No. 8. Aug. 2014, pp. 773-785. |
Nortis; “Bridging the Gap Between in Vitro and in Vivo Research”; 16 Pages; (2015); https://www.nortisbio.com/. |
Organovo, “Pioneering Bioprinted Tissues To Treat Disease”; 2 Pages; (Downloaded Mar. 9, 2020) http://organovo.com/. |
Otsuka et al, “Two-dimensional multiarray formation of hepatocyte spheroids on a microfabricated PEG-brush surface.” ChemBioChem 2004; 5:850-855. |
Peshwa et al. “Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids.” In Vitro Cell Dev Biol Anim 1996;32:197-203. |
Rezende et al, “Scalable Biofabrication of Tissue Spheroids for Organ Printing”; Sciverse Science Direct, Procedia CIRP 5, (2013) 276-281. |
Sa et al. “Round-bottomed Honeycomb Microwells: Embryoid body shape correlates with stem cell fate” Journal of Developmental Biology and Tissue Engineering vol. 4(2), pp. 12-22, May 2012. |
Sakai et al, “Detachably Assembled Microfluidic Device for Perfusion Culture and Post-Culture Analysis of Spheroid Array”; Biotechnol. J. 2014, 9, 971-979. |
Sakai et al, “Large-scale preparation and function of porcine hepatocyte spheroids.” Int J Artif Organs 1996; vol. 19, No. 5, pp. 294-301. |
Sakai et al, “Technique for the Control of Spheroid Diameter Using Microfabricated Chips”; Sciencedirect, Acta Biomaterialia 3 (2007) 1033-1040. |
Sart et al, “Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties and applications” Tissue engineering, 2013, Part B, vol. 00, No. 00, 1-16. |
Satoh et al, “A Pneumatic Pressure-Driven Multi-Throughput Microfluidic Circulation Culture System” Lab Chip, 2016, 16, 2339-2348. |
Seldon et al; “Evaluation of Encapsulated Liver Cell Spheroids in a Fluidised-Bed Bioartificial Liver for Treatment of Ischaemic Acute Liver Failure in Pigs in the Translational Setting”: PLOS One; Dec. 2013, vol. 8, Issue 12, 12 Pages. |
Stemcell Technologies, Reproducible and Uniform Embryoid Bodies Using AggreWell Plates, StemCell Technologies, Version 3.0.0, Mar. 2011, Catalog #29146, pp. 1-28. |
Takezawa et al. “Morphological and immunocytochemical characterization of a heterospheroid composed of fibroblasts and hepatocytes.” J Cell Sci 1992;101:495-501. |
Tara; “Innovating Predictive Cardiac Physiology”; 4 Pages; (2019) http://tarabiosystems.com/. |
The Lab Depot(Registered) Products for Discovery Lab Supplies; Shake Flasks, 3 and 4 Baffles Product Information; 5 Pages (2019). |
Tissue Dynamics, “Disruptive Drug Development”; 3 Pages; (Downloaded Mar. 9, 2020); https://www.tissuedynamics.com/. |
Tissuse, “Emulating Human Biology, Pioneering Human-On-A-Chip Developments”; 1 Page; (Downloaded Mar. 9, 2020) https://www.tissuse.com/en/. |
Tobe et al., “Receptor-mediated formation of multilayer aggregates of primary cultured adult rat hepatocytes on tactose-subsliluled polystyrene” Biochem Biophys Res Commun 1992; 184(1):225-230. |
Tong et al, “Long-term culture of adult rat hepatocyte spheroids.” Exp Cell Res 1992; 200:326-332. |
Truckemuller, et al., Thermoforming of Film-Based Biomedical Microdevices, Adv. Mater. 2011, 23, pp. 1311-1329. |
Tung et al, “High-throughput 3D spheroid culture and drug testing using 384 hanging drop array” Analyst, 2011, 136 (3), 473-478. |
Uchida et al; “An Injectable Spheroid System With Genetic Modification for Cell Transplantation Therapy”; Biomaterials, 35 (2014) 2499-2506. |
Urich et al; “Multicellular Self-Assembled Spheroidal Model of the Blood Brain Barrier”; Scientific Reports; 3, 1500, 8 Pages. |
Vinci et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation, BMC Biology 2012, 10:29. |
Weegman et al, “Nutrient Regulation By Continuous Feeding Removes Limitations On Cell Yield in the Large-Scale Expansion of Mammalian Cell Spheroids”; PLOS ONE, 2013, vol. 8, Issue 10, e76611, 10 Pages. |
Wikipedia; “Antiroll Tanks”; 3 Pages; Page Last Edited May 23, 2019. |
Wrighton et al, “Forces of Change: Mechanics Underlying Formation of Functional 3D Organ Buds” Cell Stem Cell, May 7, 2015; 16(5): 453-454. |
Xu et al, “Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers.” Toxicol Appl Pharmacol 2003; 189:100-111. |
Yamada et al, “Efficient induction of hepatocyte spheroids in a suspension culture using a water-soluble synthetic polymer as an artificial matrix.” J Biochem 1998; 123:1017-1023. |
Achilli et al, “Advances in the Formation, Use and Understanding of Multi-Cellular Spheroids”, Expert Opin. Biol. Ther. (2012) 12(10):1347-1360. |
Alepee et al. “State of the art 3D cultures (organs-on-a-chip) in safety testing and pathophysiology” Trnasatlantic Think Tank for Toxicology, t4 Workshop Report, Altex 31 4/14, pp. 441-477, retrieved from: http://dx.doi.org/10.14573/altex1406111 (Jul. 14, 2014). |
Aline; “We Engineer Microfluidic Products” ; 7 Pages; (2020) https:/alineinc.com/. |
Anada et al; “An Oxygen-Permeable Spheroid Culture System for the Prevention of Central Hypoxia and Necrosis of Spheroids”; Biomaterials, 33, (2012) 8430-8441. |
AxoSIM, Nerve-On-A-Chip Mini-Brain About Team; 6 Pages; (Downloaded Mar. 9, 2020); http://axosim.com/. |
Bartosh et al; “Aggregation of Human Mesenchymal Stromal Cells (MSCS) Into 3D Spheroid Enhances Their AntiInflammatory Properties”; PNAS, Aug. 3, 2010, vol. 107, No. 31 pp. 13724-13729. |
Bioivt Elevating Science(Registered); 6 Pages; (2020); http://www.hepregen.com/. |
Carver et al; Multicellular Tumor Spheroids as a Model for Assessing Delivery of Oligonucleotides in Three Dimensions; Molecular Therapy-Nucleic Acids (2014) 3, E153; 8 Pages. |
Chen et al., “Microfluidic array for three-dimensional perfusion culture of human mammary epithelial cells.” Biomed Microdevices, vol. 13 (2011), pp. 753-758. |
Cheng et al, “MICRORNA-34a Targets Forkhead Box J2 To Modulate Differentiation of Endothelial Progenitor Cells in Response To Shear Stress”, J Mol Cell Cardiol. 74 (2014) 4-12. |
Choi et al., “Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo[a]pyrene toxicity” Toxicology in Vitro, vol. 18, pp. 393-402, 2004. |
CN-BIO, “Transforming Drug Discovery and the Lives of Patients”; 5 Pages; (2020) http://cn-bio.com/. |
Colazzo et al., “Shear Stress and VEGF Enhance Endothelial Differentiation of Human Adipose-Derived Stem Cells”, Growth Factors, 2014, 32(5):139-149. |
Corning Life Sciences Product Portfolio; 5 Pages Saved Mar. 6, 2020. |
Corning(Registered) HTS Transwell(Registered)-96 Tissue Culture Systems, Permeable Supports for High Throughput Screening Applications; 2 Pages (2004). |
Dolznig and Walzl, “Organotypic spheroid cultures to study tumor- stroma interactions during cancer development.” Drug discovery today, V 8., No. 2-3, 2011, 113-118. |
Domansky et al, “Perfused Multiwell Plate For 30 Liver Tissue Engineering”, Lab Chip, 2010, 10:51-58. |
Elveflow; “Microfluidics Innovation Center”; 6 Pages; (Downloaded Mar. 9, 2020); https://www.elveflow.com. |
Emulate; 6 Pages; (2019) https://emulatebio.com/. |
Endo et al., “Gene transfection to spheroid culture system on micropatterned culture plate by polyplex nanomicelle: a novel platform of genetically-modified cell transplantation”, Drug Deliv. and Transl. Res., 2012, vol. 2, p. 398-405. |
Engelberg et al, “Essential operating principles for tumor spheroid growth”, BMC Systems Biology 2008, 2:110, 19 pages. |
European Patent Application No. 14727673.7; Communication pursuant to Article 94(3) EPC dated Aug. 6, 2018; 5 pages; European Patent Office. |
Friedrich et al. “Spheroid-based drug screen: considerations and practical approach.” Nature protocols, 2009, vol. 4 No. 3, 309-323. |
Friedrich et al: “Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge?” Int J Radiat Biol 2007, 83:849-871. |
Frith et al. “Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.” Tissue engineering, 2010, 16, No. 4, 735-749. |
Fukuda et al, “Efficacy of a polyurethane foam/spheroid artificial liver by using human hepaloblastoma cell line (Hep G2)”, Cell Transplantation, 2003, 12:51-58. |
G-Plate: Accelerate your cell cultures to the next dimension, “An original cell culture model allowing for island-shaped 3D cell aggregates”, 1 page, retrieved Sep. 8, 2015. |
GeoCHEM Incorporated, Product Line; hllps://www.geocheminc.com, 4 Pages; (2020). |
HμREL (Registered) Corporation, Bioanalytic Tools Company; 2 Pages; (2013); http://hurelcorp.com/. |
Haycock, “3D cell culture: a review of current approaches and techniques”, Methods Mol Biol, 2011; 695:1-15. |
Hirschhaeuser et al., “Mulicellular tumor spheroids: An underestimated tool is catching up again.” Journal of Biotechnology, 2010, 148, 3-15. |
Howes et al; “3-Dimensional Culture Systems for Anit-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared To Monolayer Culture Systems”; PLOS One; Sep. 2004, vol. 9, Issue 9, 11 Pages. |
Hribar et al; “Nonlinear 3D Projection Printing of Concave Hydrogel Microstructures for Long-Term Multicellular Spheroid and Embryoid Body Culture”; Lab Chip, 2015, 15, 2412-2418. |
Hwang et al.; “Microwell-Mediated Control of Embryoid Body Size Regulates Embryonic Stem Cell Fate Via Differential Expression of WNT5A and WNT11”; PNAS; Oct. 6, 2009; vol. 106, No. 40. pp. 16978-16983. |
International Search Report and Written Opinion of the International Searching Authority; PCT/US14/35635; Mailed Aug. 22, 2014; 9 Pages; European Patent Office. |
Jeon et al, “Combined Effects of Flow-Induced Shear Stress and Micropatterned Surface Morphology On Neuronal Differentiation of Human Mesenchymal Stem Cells” J Biosci Bioeng, 2014, 117(2):242-247. |
Jiang et al, “Shear Enhances Thrombopoiesis and Formation of Microparticles That Induce Megakaryocytic Differentiation of Stem Cells”, Blood, Sep. 25, 2014; 124(13):2094-2103. |
Kelm et al, “Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types”, Biotechnology and Bioengineering 2003; 83(2):173-180. |
Kim et al, “Shear Stress Induced By an Interstitial Level of Slow Flow Increases the Osteogenic Differentiation of Mesenchymal Stem Cells Through Taz Activation” PLoS ONE, Mar. 21, 2014; 9(3), e92427, 9 pages. |
Koide et al, “Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments”, Exp Cell Res 1990; 186:227-235. |
Kunz-Schughart et al: “The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.” J Biomol Screen 2004, 9:273-285. |
Kutsuzawa et al, “Highly Robust Protein Production By Co-Culture of Cho Spheroids Layered On Feeder Cells in Serum-Free Medium”; Colloid Polym Sci (2014) 292; 839-848. |
Labusca et al. “Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential”, Cell Tissue Res. Mar. 2012 ; 347(3): 701-711. |
Labusca, “Scaffold free 3D culture of mesenchymal stem cells; implications for regenerative medicine”, J Transplant Stem Cel Biol 2015 2(1): 8. |
Landry et al, “Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities” J Cell Biol 1985; 101:914-923. |
Lau et al., “Evaluation of a Novel in Vitro CACO-2 Hepatocyte Hybrid System for Predicting in Vivo Oral Bioavailability” Drug Metabolism and Disposition, vol. 32, No. 9, pp. 937-942, 2004. |
Liquid Surge Control, LLC; “The Latest in Drop-In Baffle Technology”; 2 Pages; (2019). |
Liu et al. “Quasi-spherical microwells on superhydrophobic substrates for long term culture of multicellular spheroids and high throughput assays” Biomaterials and Cancer 35 (2014) pp. 6060-6068. |
Liu et al; “Advanced Micromachining of Concave Microwells for Long Term On-Chip Culture of Multicellular Tumour Spheroids”, ACS Appl. Mater. Interfaces, 2014, 35 Pages. |
Lu et al. “Galactosylated PVDF membrane promotes hepatocyte attachment and functional maintenance.” Biomaterials 2003;24:4893-903. |
“Laboratory Flasks Selection Guide: Types, Features, Applications”, Engineering360, <https://www.globalspec.com/learnmore/labware_scientific_instruments/labware_consumables/laboratory_flasks#:˜:text=Laboratory%20flasks%20are%20lab%20vessels, the%20opening%20at%20the%20neck.> accessed Apr. 8, 2022 (Year: 2022). |
Brandrup et al., “Polymer Handbook”, Fourth Edition, Wiley-Interscience Publication, , Permeability and diffusion data, 1999, 9 pages (Contributors; Preface). |
Hsiao et al., “Effects of 3D Microwell Culture on Initial Fate Specification in Human Embryonic Stem Cells”, Published in final edited form as AIChE J. vol. 60 No. 4, Apr. 2014, pp. 1225-1235. |
Huang et al., “Preparation of dense Ta-LLZO/MgO composite Li-ion solid electrolyte: Sintering, microstructure, performance and the role of MgO”, Journal of Energy Chemistry, vol. 39, 2019, pp. 8-16. |
International Search Report and Written Opinion of the International Searching Authority; PCT/US2021/059622; mailed on May 23, 2022, 11 pages; European Patent Office. |
Junji Fukuda et al., “Hepatocyte Spheroid Arrays Inside Microwells Connected With Microchannels”, Biomicrofluidics 5, 2011, pp. 10. |
Lin et al., “La2Zr2O7 and MgO co-doped composite Li-Garnet solid electrolyte”, Journal of Energy Chemistry, vol. 40, 2020, pp. 132-136. |
Lonza Inc., “SeaPrep Agarose: An Ultralow Gelling, Soft Agarose”, Available Online at <http://www.lonzabio.jp/catalog/pdf/pd/PD031.pdf>, 2007, pp. 1-4. |
Martin et al., “Agarose And Methylcellulose Hydrogel Blends For Nerve Regeneration Applications”, J. Neural Eng., vol. 5, 2008, pp. 221-231. |
McMillan, “Shear stress in microfluidic devices” Darwin Microfludics interner article (Year: 2017). |
Polyimide: Japan Polyimide and Aromatic Polymers Study Group, 2010, pp. 364-371 Table 2. |
WO 2017/077163 (Year: 2017). |
WO-2008149039 translation (Year: 2008). |
Yang et al.,“An Agarose-Gel Based Method for Transporting Cell Lines”, Current Chemical Genomics, vol. 3, Jan. 2009, pp. 50-53. |
Zuidema et al., “Fabrication And Characterization Of Tunable Polysaccharide Hydrogel Blends For Neural Repair”, Acta Biomaterialia, vol. 7, No. 4, Apr. 2011, pp. 1634-1643. |
Number | Date | Country | |
---|---|---|---|
20200392453 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
61817539 | Apr 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15708473 | Sep 2017 | US |
Child | 17005801 | US | |
Parent | 14087906 | Nov 2013 | US |
Child | 15708473 | US |